- Helical coils augment embolization of the middle meningeal artery for treatment of chronic subdural hematoma: A technical note
-
Wali AR, Himstead A, Bravo J, Brandel MG, Hirshman BR, Pannell JS, Nguyen AD, Santiago-Dieppa DR
- KMID: 2543519
- J Cerebrovasc Endovasc Neurosurg.
- 2023 Jun;25(2):214-223.
- doi: 10.7461/jcen.2023.E2022.08.001
Embolization of the middle meningeal artery (MMA) is a safe and effective adjunct in the treatment of chronic subdural hematoma. While prior authors describe the use of coils to assist... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimizing suction force in mechanical thrombectomy: Priming the aspiration tubing with air versus saline
-
Wali AR, Sindewald RW, Brandel MG, Bravo J, Steinberg JA, Pannell JS, Khalessi AA, Santiago-Dieppa DR
- KMID: 2559435
- J Cerebrovasc Endovasc Neurosurg.
- 2024 Sep;26(3):260-264.
- doi: 10.7461/jcen.2024.E2023.09.003
Objective: We sought to investigate how priming the tube between air versus air mixed with saline ex vivo influenced suction force. We examined how priming the tube influenced peak suction... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety of middle meningeal artery embolization for treatment of subdural hematoma: A nationwide propensity score matched analysis
-
McCann CP, Brandel MG, Wali AR, Steinberg JA, Pannell JS, Santiago-Dieppa DR, Khalessi AA
- KMID: 2549443
- J Cerebrovasc Endovasc Neurosurg.
- 2023 Dec;25(4):380-389.
- doi: 10.7461/jcen.2023.E2023.05.003
Objective: Middle meningeal artery embolization (MMAe) has burgeoned as a treatment for chronic subdural hematoma (cSDH). This study evaluates the safety and short-term outcomes of MMAe patients relative to traditional... -
- CITED
-
- Close
- SHARE
-
- Close
- ALARA principles in practice: reduced frame and pulse rates for middle meningeal artery embolization
-
Wali AR, Sindewald RW, Brandel MG, Pathuri S, Hirshman BR, Bravo JA, Steinberg JA, Pannell JS, Khalessi A, Santiago-Dieppa DR
- KMID: 2559439
- J Cerebrovasc Endovasc Neurosurg.
- 2024 Sep;26(3):293-297.
- doi: 10.7461/jcen.2024.E2024.02.003
Objective: As the prevalence of neuroendovascular interventions increases, it is critical to mitigate unnecessary radiation for patients, providers, and health care staff. Our group previously demonstrated reduced radiation dose and... -
- CITED
-
- Close
- SHARE
-
- Close
- Reducing frame rate and pulse rate for routine diagnostic cerebral angiography: ALARA principles in practice
-
Wali AR, Pathuri S, Brandel MG, Sindewald RW, Hirshman BR, Bravo JA, Steinberg JA, Olson SE, Pannell JS, Khalessi A, Santiago-Dieppa D
- KMID: 2554045
- J Cerebrovasc Endovasc Neurosurg.
- 2024 Mar;26(1):46-50.
- doi: 10.7461/jcen.2023.E2023.01.007
Objective: Diagnostic cerebral angiograms (DCAs) are widely used in neurosurgery due to their high sensitivity and specificity to diagnose and characterize pathology using ionizing radiation. Eliminating unnecessary radiation is critical... -
- CITED
-
- Close
- SHARE
-
- Close
- Implications and limitations of cellular reprogramming for psychiatric drug development
-
Tobe BT, Brandel MG, Nye JS, Snyder EY
- KMID: 2154278
- Exp Mol Med.
- 2013 Nov;45(11):e59.
Human-induced pluripotent stem cells (hiPSCs) derived from somatic cells of patients have opened possibilities for in vitro modeling of the physiology of neural (and other) cells in psychiatric disease states.... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical revascularization for Moyamoya disease in the United States: A cost-effectiveness analysis
-
Wali AR, Santiago-Dieppa DR, Srinivas S, Brandel MG, Steinberg JA, Rennert RC, Mandeville R, Murphy JD, Olson S, Pannell JS, Khalessi AA
- KMID: 2514333
- J Cerebrovasc Endovasc Neurosurg.
- 2021 Mar;23(1):6-15.
- doi: 10.7461/jcen.2021.E2020.07.002
Objective: Moyamoya disease (MMD) is a vasculopathy of the internal carotid arteries with ischemic and hemorrhagic sequelae. Surgical revascularization confers upfront peri-procedural risk and costs in exchange for long-term protective... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiplatelet therapy within 24 hoursof tPA: lessons learned from patientsrequiring combined thrombectomyand stenting for acute ischemic stroke
-
Brandel MG, Elsawaf Y, Rennert RC, Steinberg JA, Santiago-Dieppa DR, Wali AR, Olson SE, Pannell JS, Khalessi AA
- KMID: 2500067
- J Cerebrovasc Endovasc Neurosurg.
- 2020 Mar;22(1):1-7.
- doi: 10.7461/jcen.2020.22.1.1
Objective: Although stroke guidelines recommend antiplatelets be started 24 hours after tissue plasminogen activator (tPA), select mechanical thrombectomy (MT) patients with luminal irregularities or underlying intracranial atherosclerotic disease may benefit from earlier antiplatelet... -
- CITED
-
- Close
- SHARE
-
- Close
